A single-arm, prospective, multicenter, real-world study of efficacy and safety of fuquinitinib combined with capecitabine in maintenance therapy after first-line chemotherapy in metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Interventions: Experimental group:The dose of fuquinitinib was 5mg, qd po, d1-14, q3w;The dose of capecitabine was 1000mg/m2, bid po, d1-14, q3w. Primary outcome(s): Progression-free survival Study Design: Single arm
创建时间：
2023-08-15
